electroCore to Participate at 35th Annual Roth Conference
09 Março 2023 - 10:00AM
electroCore, Inc. (the “Company”), (NASDAQ: ECOR) a
commercial-stage bioelectronic medicine and wellness company, today
announced that electroCore’s Chief Strategy Officer, Joshua Lev,
will participate in a fireside chat at the 35th Annual Roth
Conference in Dana Point, California during March 12-14,
2023.
Roth ConferenceDate: Tuesday, March 14,
2023Time: 1:00 PM PTEvent: Fireside ChatelectroCore will also be
available for one-on-one meetings during the conference. For more
information or to schedule a meeting, please visit the conference
page here or email Investor Relations at
ecor@cg.capital.
About electroCore,
Inc.electroCore, Inc. is a commercial stage bioelectronic
medicine and wellness company dedicated to improving health through
its non-invasive vagus nerve stimulation (“nVNS”) technology
platform. Our focus is the commercialization of medical devices for
the management and treatment of certain medical conditions and
consumer product offerings utilizing nVNS to promote general
wellbeing and human performance in the United States and select
overseas markets.For more information, visit
www.electrocore.com.
Investors:Rich CockrellCG
Capital404-736-3838ecor@cg.capital
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024